In March, Johnson & Johnson tapped mobile health tech player Welldoc to incorporate its diabetes management platform into J&J’s latest blood glucose monitor. Now, the pair is announcing FDA clearance of the wireless integration between the two systems.
It's easy to see why EpiPen has become the focus of America's fury over drug prices. It treats potentially deadly allergic reactions — for example, in a child who is stung by a bee — and its price has spiked by over 500% in a few years.
French pharmaceutical company Sanofi Pasteur says it's no longer profitable to make one of the most vital anti-venom for snakebites in Africa.Fav-Afrique counters the toxins of some of the world's most deadly venomous snakes.